(D-Ala2)-Leucineenkephalin-Arg

(D-Ala2)-Leucineenkephalin-Arg

81733-79-1

C35H51N9O8

(D-ALA2)-LEUCINE ENKEPHALIN-ARG; ala(2)-arg(6)-enkephalin-le; cyl)-; inine; l-arginine,n(sup2)-(n-(n-(n-(l-tyrosyl-d-alanyl)glycyl)-l-phenylalanyl)-l-leu; n(sup2)-(n-(n-(n-(l-tyrosyl-d-alanyl)glycyl)-l-phenylalanyl)-l-leucyl)-l-arg; tyrosyl-d-alanyl-glycyl-phenylalanyl-leucyl-arginine; enkephalin-Leu, Ala(2)-Arg(6)-;(D-ALA2)-LEUCINE ENKEPHALIN-ARG;2-D-Alanine-1-6-beta-neoendorphin (human); BRN 4287455; Dalargin; N(sup 2)-(N-(N-(N-(L-Tyrosyl-D-alanyl)glycyl)-L-phenylalanyl)-L-leucyl)-L-arginine; Tageflar; Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine; UNII-V13505565P; 1-6-beta-Neoendorphin (human), 2-D-alanine-; L-Arginine, N(sup 2)-(N-(N-(N-(L-tyrosyl-D-alanyl)glycyl)-L-phenylalanyl)-L-leucyl)-;

725.83

C[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](Cc2ccc(cc2)O)N

GDPHPXYFLPDZGH-XBTMSFKCSA-N

1S/C35H51N9O8/c1-20(2)16-27(32(49)43-26(34(51)52)10-7-15-39-35(37)38)44-33(50)28(18-22-8-5-4-6-9-22)42-29(46)19-40-30(47)21(3)41-31(48)25(36)17-23-11-13-24(45)14-12-23/h4-6,8-9,11-14,20-21,25-28,45H,7,10,15-19,36H2,1-3H3,(H,40,47)(H,41,48)(H,42,46)(H,